title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Thursday,20220526T161527,https://www.benzinga.com/markets/options/22/05/27422270/52-weeks-high-and-low-article,CRNX,0.048646,Neutral,0.007099
"Aquestive Therapeutics  ( AQST )  Reports Q2 Loss, Tops Revenue Estimates",20240806T213507,https://www.zacks.com/stock/news/2317374/aquestive-therapeutics-aqst-reports-q2-loss-tops-revenue-estimates,CRNX,0.205225,Neutral,0.0
"Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar",20240111T220100,https://www.prnewswire.com/news-releases/gastroenteropancreatic-neuroendocrine-tumors-market-to-showcase-a-significant-growth-by-2032-evaluates-delveinsight--key-players---eli-lilly-and-company-phanes-therapeutics-camurus-ab-advanced-accelerator-applications-pharma-302032286.html,CRNX,0.025139,Neutral,0.019544
88 Biggest Movers From Yesterday,20220526T090859,https://www.benzinga.com/news/22/05/27411905/88-biggest-movers-from-yesterday,CRNX,0.071534,Neutral,0.104798
88 Biggest Movers From Yesterday,20220526T090859,https://markets.businessinsider.com/news/stocks/88-biggest-movers-from-yesterday-1031490389,CRNX,0.044015,Neutral,0.101725
"Congenital Adrenal Hyperplasia Treatment Drug Market to Exhibit Immense Growth During the Study Period  ( 2019-2032 ) , Predicts DelveInsight",20231221T220100,https://www.prnewswire.com/news-releases/congenital-adrenal-hyperplasia-treatment-drug-market-to-exhibit-immense-growth-during-the-study-period-20192032-predicts-delveinsight-302020741.html,CRNX,0.055946,Neutral,0.093941
"US Stocks Open Higher; Dow Jumps 150 Points - NovaBay Pharmaceuticals  ( AMEX:NBY ) , Crinetics Pharmaceuticals  ( NASDAQ:CRNX ) ",20230911T133950,https://www.benzinga.com/news/earnings/23/09/34441875/us-stocks-open-higher-dow-jumps-150-points,CRNX,0.136888,Somewhat-Bullish,0.175165
Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket - Crinetics Pharmaceuticals  ( NASDAQ:CRNX ) ,20230911T121018,https://www.benzinga.com/news/23/09/34436883/why-tenon-medical-shares-are-trading-lower-by-34-here-are-20-stocks-moving-premarket,CRNX,0.204936,Somewhat-Bullish,0.204457
53 Biggest Movers From Yesterday,20220401T081847,https://www.benzinga.com/news/22/04/26417154/53-biggest-movers-from-yesterday,CRNX,0.06356,Neutral,0.00558
"Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - Crinetics Pharmaceuticals  ( NASDAQ:CRNX ) ",20221003T120000,https://www.benzinga.com/pressreleases/22/10/g29115877/crinetics-pharmaceuticals-appoints-dana-pizzuti-m-d-as-chief-development-officer,CRNX,0.060236,Neutral,0.0
